相关实验视频

Updated: Jan 18, 2026

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

三种治疗抗体与多态Aβ寡合体结合的不同形状选择

Honglin Xu¹, Yan Zheng¹, Ganggang Bai²

¹Engineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China.

International journal of biological macromolecules

|January 15, 2026

概括

这项研究模拟了阿尔茨海默病 (AD) 粉样蛋白-β (Aβ) 寡合体和三种AD疗法之间的相互作用. 不同的抗体表现出不同的结合机制,为开发更有效的Aβ向治疗提供了洞察力.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
结构生物学结构生物学

背景情况:

阿尔茨海默氏症 (AD) 病原发生涉及粉样β (Aβ) 聚合物,可溶性寡合物具有高度的神经毒性.
Aβ聚合物的结构多样性使得开发有效的抗体疗法变得复杂.
目前的阿尔茨海默症抗体治疗显示出不同的疗效,不同Aβ多态的分子识别机制尚不清楚.

研究的目的:

为了阐明Aβ寡合体和三种FDA批准的AD抗体之间的分子相互作用.
了解差异抗体结合和治疗疗效的结构基础.
建立下一代Aβ向治疗的设计原则.

主要方法:

抗体-Aβ寡合体相互作用的计算模拟.
结合接口的分析和表位的识别.
对阿杜卡努马布,莱卡尼马布和多纳尼马布的结合方式进行比较.

主要成果:

阿杜卡努马布表现出多态依赖的结合,准N端表位和跨β结构.
莱卡尼马布使用扩展接口同时结合多个Aβ N-终端.
多纳尼马布通过CDRL1主导模式识别特定的聚合物,该模式由pE3修改定.

结论:

不同的抗体对Aβ聚合物的识别有不同的结构机制.
这些发现为AD治疗中观察到的临床结果提供了分子解释.
该研究提供了设计原则,用于开发针对特定Aβ病理形式的向治疗方法.

关键词:

这就是Aducanumab.阿尔茨海默氏症的疾病是阿尔茨海默氏症.粉样蛋白-β的小分子.没有人可以让我们这样做.莱卡内马布 (Lecanemab) 是一个分子模拟的分子模拟.

更多相关视频

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

Published on: April 23, 2010

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...